Literature DB >> 11371751

Immunological update on multiple sclerosis.

R Hohlfeld1, H Wekerle.   

Abstract

The present review of the recent literature focuses on antigen-specific immune reactions in multiple sclerosis. New techniques have allowed precise quantitative analysis of the antigen-receptor repertoire of infiltrating T cells in the multiple sclerosis brain. Novel candidate autoantigens, including B-cell autoantigens, have been identified. 'Humanized' animal models allow the functional characterization of human immune molecules in vivo. Finally, several therapeutic trials have recently assessed the clinical benefit of selective immunotherapies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11371751     DOI: 10.1097/00019052-200106000-00006

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  29 in total

Review 1.  All in the head: obstacles for immune rejection of brain tumours.

Authors:  Paul R Walker; Thomas Calzascia; Pierre-Yves Dietrich
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

Review 2.  Cytokine-based immunointervention in the treatment of autoimmune diseases.

Authors:  L Adorini
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 3.  What do we know about the mechanism of action of disease-modifying treatments in MS?

Authors:  Hans-Peter Hartung; Amit Bar-Or; Yannis Zoukos
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

4.  Role of Bioflavonoid Quercetin on Expression of Urea Cycle Enzymes, Astrocytic and Inflammatory Markers in Hyperammonemic Rats.

Authors:  Sivamani Kanimozhi; Perumal Subramanian; Sakkaravarthy Shanmugapriya; Subramanian Sathishkumar
Journal:  Indian J Clin Biochem       Date:  2016-05-05

5.  9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.

Authors:  Jihong Xu; Paul D Drew
Journal:  J Neuroimmunol       Date:  2005-11-21       Impact factor: 3.478

6.  Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets.

Authors:  Vamshi K Nimmagadda; Christopher T Bever; Narasimha R Vattikunta; Saifi Talat; Vakas Ahmad; Naveen K Nagalla; David Trisler; Susan I V Judge; Walter Royal; Krish Chandrasekaran; James W Russell; Tapas K Makar
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

7.  Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders.

Authors:  Paolo A Muraro; Klaus-Peter Wandinger; Bibiana Bielekova; Bruno Gran; Adriana Marques; Ursula Utz; Henry F McFarland; Steve Jacobson; Roland Martin
Journal:  Brain       Date:  2003-01       Impact factor: 13.501

8.  Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4+ T cells.

Authors:  Hongwei Xu; Zhi-Ying Wu; Fang Fang; Lan Guo; Doris Chen; John Xi Chen; David Stern; Gregory A Taylor; Hong Jiang; Shirley ShiDu Yan
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

9.  T cells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer's disease.

Authors:  Yair Fisher; Anna Nemirovsky; Rona Baron; Alon Monsonego
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

Review 10.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.